Disclosed herein are pyrazole glucokinase activators of the formula (I)
wherein R1 to R4 are as defined in the specification and claims, useful for the treatment of metabolic diseases and disorders, preferably diabetes mellitus.
Disclosed herein are pyrazole glucokinase activators of the formula (I)
useful for the treatment of metabolic diseases and disorders, preferably diabetes mellitus.